Search company, investor...

Predict your next investment

Investment Bank
apeironpartners.com

Investments

2

Portfolio Exits

1

About Apeiron Partners

Apeiron Partners operates as a boutique investment bank focused exclusively on the life sciences.

Headquarters Location

33 Broad St. Suite 1100

Boston, Massachusetts, 02109,

United States

Want to inform investors similar to Apeiron Partners about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Expert Collections containing Apeiron Partners

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Apeiron Partners in 1 Expert Collection, including Synthetic Biology.

S

Synthetic Biology

382 items

Apeiron Partners Investments

2 Investments

Apeiron Partners has made 2 investments. Their latest investment was in EnBiotix as part of their Series A on May 5, 2016.

CBI Logo

Apeiron Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

5/12/2016

Series A

EnBiotix

Yes

3

8/7/2006

Series A

Subscribe to see more

$99M

Subscribe to see more

0

Date

5/12/2016

8/7/2006

Round

Series A

Series A

Company

EnBiotix

Subscribe to see more

Amount

$99M

New?

Yes

Subscribe to see more

Co-Investors

Sources

3

0

Apeiron Partners Portfolio Exits

1 Portfolio Exit

Apeiron Partners has 1 portfolio exit. Their latest portfolio exit was EnBiotix on December 30, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

12/30/2021

Acquired

$99M

4

Date

12/30/2021

Exit

Acquired

Companies

Valuation

$99M

Acquirer

Sources

4

Apeiron Partners Team

1 Team Member

Apeiron Partners has 1 team member, including current Managing Director, Jeffrey D Wager.

Name

Work History

Title

Status

Jeffrey D Wager

EnBiotix, Artisan Pharma, and Medical Science Partners

Managing Director

Current

Name

Jeffrey D Wager

Work History

EnBiotix, Artisan Pharma, and Medical Science Partners

Title

Managing Director

Status

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.